Compare ACHC & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACHC | CNMD |
|---|---|---|
| Founded | 2005 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2011 | 1995 |
| Metric | ACHC | CNMD |
|---|---|---|
| Price | $23.99 | $36.88 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 6 |
| Target Price | $21.64 | ★ $48.00 |
| AVG Volume (30 Days) | ★ 3.3M | 356.1K |
| Earning Date | 05-11-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.09% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.51 |
| Revenue | ★ $3,312,769,000.00 | $1,374,724,000.00 |
| Revenue This Year | $5.08 | $0.82 |
| Revenue Next Year | $5.98 | $5.48 |
| P/E Ratio | ★ N/A | $24.21 |
| Revenue Growth | 5.04 | ★ 5.18 |
| 52 Week Low | $11.43 | $35.37 |
| 52 Week High | $31.04 | $61.13 |
| Indicator | ACHC | CNMD |
|---|---|---|
| Relative Strength Index (RSI) | 62.82 | 34.69 |
| Support Level | $23.02 | $35.37 |
| Resistance Level | $25.07 | $46.08 |
| Average True Range (ATR) | 1.20 | 1.37 |
| MACD | -0.38 | -0.23 |
| Stochastic Oscillator | 59.90 | 24.57 |
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.